Chelsea Bernheisel, n/a

Associate Director, Medical Affairs Operations
Sobi, Inc.

Poster(s):

• (359) Healthcare Resource Utilization in Patients with Primary Immune Thrombocytopenia Treated with Avatrombopag in the United States: REAL-AVA 2.0 Study Results
  Wednesday, October 29, 2025